Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Precision Biosciences (DTIL) Other financing activities (2018 - 2025)

Historic Other financing activities for Precision Biosciences (DTIL) over the last 6 years, with Q1 2025 value amounting to $1.0 million.

  • Precision Biosciences' Other financing activities rose 1392.27% to $1.0 million in Q1 2025 from the same period last year, while for Sep 2025 it was $1.0 million, marking a year-over-year increase of 1392.27%. This contributed to the annual value of $905000.0 for FY2024, which is N/A changed from last year.
  • Latest data reveals that Precision Biosciences reported Other financing activities of $1.0 million as of Q1 2025, which was up 1392.27% from $905000.0 recorded in Q1 2024.
  • Over the past 5 years, Precision Biosciences' Other financing activities peaked at $35.0 million during Q1 2021, and registered a low of $905000.0 during Q1 2024.
  • In the last 3 years, Precision Biosciences' Other financing activities had a median value of $1.0 million in 2025 and averaged $12.3 million.
  • Its Other financing activities has fluctuated over the past 5 years, first soared by 2544744.53% in 2021, then surged by 1392.27% in 2025.
  • Quarter analysis of 3 years shows Precision Biosciences' Other financing activities stood at $35.0 million in 2021, then tumbled by 97.41% to $905000.0 in 2024, then grew by 13.92% to $1.0 million in 2025.
  • Its Other financing activities was $1.0 million in Q1 2025, compared to $905000.0 in Q1 2024 and $35.0 million in Q1 2021.